8th Global NAFLD/MASLD Congress

Key Topics

• Automated approach for diagnosis, staging and risk assessment of NASH
• Recent Updates in NASH Pathogenesis
• Advances in Therapeutics
• Updates to the Development Pipeline: Preclinical and Clinical
• How non-invasive tests may replace liver biopsy as the referent standard for the pragmatic clinical management of NAFLD
• Advances in anti-obesity medications as well as research into the efficacy of exercise as medicine for patients with NAFLD
• Pathophysiology and treatment of pediatric NAFLD
• Relationship between type 2 diabetes and NAFLD and relevant treatments for NAFLD
• NAFLD and bariatric surgery

Who should Attend

Attendees from:

• Industry
• Hospitals and universities

NAFLD - Nonalcoholic fatty liver disease
MASLD - Metabolic dysfunction-associated steatotic liver disease
NASH - Nonalcoholic steatohepatitis.